Journal of Blood & Lymph

Rezvani AR

Publications

• Research Article
  Busulfan Dosing Literature Review
  Author(s): Cynthia L Gong, Rezvani AR, Kim T and Studdert ALCynthia L Gong, Rezvani AR, Kim T and Studdert AL
  
  Introduction: There is debate regarding the use of busulfan every 6 hours (q6 h) compared to every 24 hours (q24 h) in patients undergoing hematopoietic cell transplantation. Objectives: To review the literature to determine whether there is a significant difference between dosing busulfan q6 h vs. q24 h in adults, and to review dosing strategies to optimize daily dosing. Methods: A literature search was conducted in PubMed with the terms “busulfan” and “transplant” and “24” in all fields. Results were further refined by using the terms “busulfan” and “transplant” and “pharmacokinetics”. Titles were then reviewed for relevance, and the remaining articles reviewed by abstract. Articles deemed relevant were then read in more thorough detail, and refere.. Read More»
  DOI: 10.4172/2165-7831.1000204

  Abstract PDF